Skip to main content
Journal cover image

Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer

Conferences
Baba, T; Convery, PA; Matsumura, N; Whitaker, RS; Perry, T; Huang, Z; Mori, S; Kondoh, E; Bentley, RC; Fujii, S; Marks, JR; Berchuck, A; Murphy, SK
Published in: GYNECOLOGIC ONCOLOGY
March 2008

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

GYNECOLOGIC ONCOLOGY

ISSN

0090-8258

Publication Date

March 2008

Volume

108

Issue

3

Start / End Page

S104 / S104

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Baba, T., Convery, P. A., Matsumura, N., Whitaker, R. S., Perry, T., Huang, Z., … Murphy, S. K. (2008). Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer. In GYNECOLOGIC ONCOLOGY (Vol. 108, pp. S104–S104).
Baba, T., P. A. Convery, N. Matsumura, R. S. Whitaker, T. Perry, Z. Huang, S. Mori, et al. “Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer.” In GYNECOLOGIC ONCOLOGY, 108:S104–S104, 2008.
Baba T, Convery PA, Matsumura N, Whitaker RS, Perry T, Huang Z, et al. Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer. In: GYNECOLOGIC ONCOLOGY. 2008. p. S104–S104.
Baba, T., et al. “Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer.” GYNECOLOGIC ONCOLOGY, vol. 108, no. 3, 2008, pp. S104–S104.
Baba T, Convery PA, Matsumura N, Whitaker RS, Perry T, Huang Z, Mori S, Kondoh E, Bentley RC, Fujii S, Marks JR, Berchuck A, Murphy SK. Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer. GYNECOLOGIC ONCOLOGY. 2008. p. S104–S104.
Journal cover image

Published In

GYNECOLOGIC ONCOLOGY

ISSN

0090-8258

Publication Date

March 2008

Volume

108

Issue

3

Start / End Page

S104 / S104

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences